next-generation platinum-based compounds (Abraxis BioScience)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namenext-generation platinum-based compounds (Abraxis BioScience)
Drug Alias Namenext-generation platinum-based compounds (Platco Technologies)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA modulators
TargetsDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Africa
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPlatco Technologies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPlatco Technologies LtdAbraxis Bioscience Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A